Two Sigma Advisers’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $522K | Sell |
115,700
-27,600
| -19% | -$124K | ﹤0.01% | 1730 |
|
|
2025
Q1 | $635K | Buy |
143,300
+69,400
| +94% | +$307K | ﹤0.01% | 1676 |
|
|
2024
Q4 | $579K | Sell |
73,900
-11,100
| -13% | -$86.9K | ﹤0.01% | 1728 |
|
|
2024
Q3 | $1.12M | Sell |
85,000
-12,700
| -13% | -$167K | ﹤0.01% | 1365 |
|
|
2024
Q2 | $1.18M | Sell |
97,700
-32,700
| -25% | -$395K | ﹤0.01% | 1469 |
|
|
2024
Q1 | $2.12M | Sell |
130,400
-34,600
| -21% | -$563K | ﹤0.01% | 1192 |
|
|
2023
Q4 | $1.13M | Sell |
165,000
-37,200
| -18% | -$254K | ﹤0.01% | 1587 |
|
|
2023
Q3 | $1.1M | Sell |
202,200
-8,000
| -4% | -$43.6K | ﹤0.01% | 1479 |
|
|
2023
Q2 | $1.43M | Buy |
210,200
+1,000
| +0.5% | +$6.79K | ﹤0.01% | 1376 |
|
|
2023
Q1 | $1.05M | Buy |
209,200
+143,100
| +216% | +$717K | ﹤0.01% | 1606 |
|
|
2022
Q4 | $323K | Buy |
+66,100
| New | +$323K | ﹤0.01% | 2041 |
|
|
2022
Q2 | – | Sell |
-11,100
| Closed | -$132K | – | 2906 |
|
|
2022
Q1 | $132K | Sell |
11,100
-13,300
| -55% | -$158K | ﹤0.01% | 2456 |
|
|
2021
Q4 | $396K | Sell |
24,400
-24,600
| -50% | -$399K | ﹤0.01% | 2028 |
|
|
2021
Q3 | $1.4M | Sell |
49,000
-86,300
| -64% | -$2.46M | ﹤0.01% | 1452 |
|
|
2021
Q2 | $4.57M | Sell |
135,300
-104,800
| -44% | -$3.54M | 0.01% | 905 |
|
|
2021
Q1 | $7.26M | Buy |
240,100
+126,900
| +112% | +$3.84M | 0.02% | 698 |
|
|
2020
Q4 | $5.61M | Buy |
113,200
+12,300
| +12% | +$609K | 0.02% | 777 |
|
|
2020
Q3 | $3.87M | Buy |
100,900
+21,600
| +27% | +$829K | 0.01% | 859 |
|
|
2020
Q2 | $3.43M | Buy |
79,300
+14,900
| +23% | +$644K | 0.01% | 956 |
|
|
2020
Q1 | $1.68M | Buy |
64,400
+21,100
| +49% | +$551K | 0.01% | 1205 |
|
|
2019
Q4 | $1.35M | Buy |
+43,300
| New | +$1.35M | ﹤0.01% | 1417 |
|